HCMLY
Holcim AG
OTC Markets OTCPKUSDEQUITY
DELAYED
Last price
17.47
▲ 0.19 (1.10%)
MARKET · —
Price
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
17.50
Prev close
17.28
Day high
17.53
Day low
17.46
Volume
22.28K
Market cap
—
P/E (TTM)
—
52W range
15.45 – 21.23
Trailing performance
Returnvs SPY
1W
-0.57%
+0.8%
1M
-3.21%
-6.9%
3M
-5.82%
-8.9%
6M
-8.10%
-19.2%
YTD
-10.27%
-22.6%
1Y
+4.86%
-15.1%
3Y
+29.12%
-45.0%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Free account
3 more panels on HCMLY open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Fundamentals
Market cap—
Enterprise value—
Revenue (TTM)—
Gross profit—
EBITDA—
Net income—
EPS (TTM)—
Free cash flow—
Total cash—
Total debt—
Book value / share—
Shares outstanding—
Float—
Short % of float—
Dividend yield—
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin—
Operating margin—
Profit margin—
Return on equity—
Return on assets—
Debt / equity—
Current ratio—
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $15.72B | $16.20B | $27.01B | $29.19B | -2.9% |
| Operating revenue | $15.72B | $16.20B | $27.01B | $29.19B | -2.9% |
| Cost of revenue | $9.06B | $9.13B | $15.51B | $17.57B | -0.8% |
| Gross profit | $6.66B | $7.07B | $11.50B | $11.61B | -5.8% |
| Selling, general & admin | $4.43B | $4.77B | $7.22B | $8.70B | -7.1% |
| Total operating expense | $4.43B | $4.77B | $7.22B | $8.73B | -7.1% |
| Operating income | $2.23B | $2.30B | $4.27B | $2.88B | -3.0% |
| Net interest income | -$284.00M | -$368.00M | -$460.00M | -$424.00M | +22.8% |
| Pre-tax income | $934.00M | $2.12B | $4.17B | $4.55B | -55.9% |
| Tax provision | $474.00M | $544.00M | $999.00M | $1.03B | -12.9% |
| Net income | $13.18B | $2.93B | $3.06B | $3.31B | +350.4% |
| Net income to common | $13.18B | $2.92B | $3.04B | $3.29B | +351.0% |
| Basic EPS | 4.77 | 1.05 | 1.07 | 1.10 | +355.2% |
| Diluted EPS | 4.76 | 1.04 | 1.07 | 1.09 | +355.7% |
| EBIT | $1.29B | $2.56B | $4.74B | $5.02B | -49.6% |
| EBITDA | $2.64B | $3.89B | $6.82B | $7.87B | -32.1% |
| Basic shares | 2.76B | 2.79B | 2.84B | 3.00B | -0.9% |
| Diluted shares | 2.77B | 2.80B | 2.85B | 3.01B | -1.1% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $5.44B | $5.35B | $6.08B | $9.82B | +1.7% |
| Cash & short-term investments | $5.44B | $5.35B | $6.09B | $9.83B | +1.7% |
| Accounts receivable | $1.71B | $2.61B | $2.72B | $2.67B | -34.4% |
| Inventory | $1.72B | $3.12B | $2.81B | $2.86B | -44.9% |
| Total current assets | $9.80B | $12.19B | $12.84B | $16.78B | -19.5% |
| Property, plant & equipment | $12.53B | $20.31B | $19.34B | $20.36B | -38.3% |
| Goodwill & intangibles | $7.10B | $16.98B | $15.71B | $15.44B | -58.2% |
| Total assets | $33.60B | $54.28B | $52.69B | $57.60B | -38.1% |
| Total current liabilities | $7.40B | $9.75B | $8.90B | $8.86B | -24.1% |
| Current debt | $1.34B | $1.81B | $1.33B | $1.62B | -26.1% |
| Long-term debt | $7.39B | $11.11B | $11.79B | $13.29B | -33.5% |
| Total debt | $8.72B | $12.92B | $13.12B | $14.91B | -32.5% |
| Total liabilities | $17.52B | $26.33B | $25.90B | $27.99B | -33.5% |
| Shareholder equity | $15.38B | $27.24B | $26.00B | $28.67B | -43.5% |
| Working capital | $2.40B | $2.43B | $3.94B | $7.93B | -1.3% |
| Net tangible assets | $8.27B | $10.26B | $10.28B | $13.23B | -19.4% |
| Shares issued | 566.88M | 579.12M | 579.12M | 615.93M | -2.1% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $460.00M | $1.57B | $3.18B | $3.53B | -70.8% |
| Depreciation & amortisation | $1.35B | $1.33B | $2.08B | $2.85B | +1.7% |
| Change in working capital | -$13.00M | $195.00M | $152.00M | -$325.00M | -106.7% |
| Operating cash flow | $2.79B | $5.67B | $5.47B | $4.56B | -50.8% |
| Capital expenditure | -$1.06B | -$1.08B | -$1.50B | -$1.55B | +2.2% |
| Investing cash flow | -$1.96B | -$2.04B | -$3.47B | $2.08B | +3.8% |
| Dividends paid | -$1.71B | -$1.57B | -$1.41B | -$1.33B | -9.2% |
| Financing cash flow | -$63.00M | -$4.37B | -$5.22B | -$3.25B | +98.6% |
| Free cash flow | $1.73B | $4.58B | $3.96B | $3.01B | -62.3% |
| End cash position | $5.44B | $5.33B | $6.05B | $9.76B | +1.9% |
No filings published for this symbol yet.
Newly listed companies often have nothing on file until their first annual report.
Newly listed companies often have nothing on file until their first annual report.
| Line item | 2025-12-31 | 2025-06-30 | 2024-12-31 | YoY |
|---|---|---|---|---|
| Cash & equivalents | $5.44B | — | $5.35B | — |
| Cash & short-term investments | $5.44B | — | $5.35B | — |
| Accounts receivable | $1.71B | — | $2.61B | — |
| Inventory | $1.72B | — | $3.12B | — |
| Total current assets | $9.80B | — | $12.19B | — |
| Property, plant & equipment | $12.53B | $12.53B | $20.31B | +0.0% |
| Goodwill & intangibles | $7.10B | $7.14B | $16.98B | -0.5% |
| Total assets | $33.60B | — | $54.28B | — |
| Total current liabilities | $7.40B | $6.18B | $9.75B | +19.7% |
| Current debt | $1.34B | — | $1.81B | — |
| Long-term debt | $7.39B | — | $11.11B | — |
| Total debt | $8.72B | — | $12.92B | — |
| Total liabilities | $17.52B | $17.69B | $26.33B | -1.0% |
| Shareholder equity | $15.38B | $14.64B | $27.24B | +5.0% |
| Working capital | $2.40B | — | $2.43B | — |
| Net tangible assets | $8.27B | $7.51B | $10.26B | +10.2% |
| Shares issued | 566.88M | 566.88M | 579.12M | 0.0% |
No filings published for this symbol yet.
Newly listed companies often have nothing on file until their first annual report.
Newly listed companies often have nothing on file until their first annual report.
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
Consensus—
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders—
Held by institutions—
Institutions holding—
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
17.43
+0.22% from price
SMA 20
17.74
-1.50% from price
SMA 50
18.19
-3.96% from price
SMA 100
18.31
-4.60% from price
SMA 200
18.42
-5.14% from price
EMA 12
17.51
-0.23% from price
EMA 26
17.77
-1.68% from price
EMA 50
18.01
-3.01% from price
RSI (14)
44.3
Neutral
MACD (12,26,9)
-0.26
Hist -0.02
ATR (14)
0.33
1.87% of price
Realised vol 30D
26.5%
Annualised
Bollinger upper
18.55
20, 2σ
Bollinger lower
16.93
20, 2σ
50 / 200 cross
Death
18.19 vs 18.42
Trend bias
Below 200
-5.14%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
1.30
More volatile than market
Correlation to SPY
0.56
Loosely linked
Realised vol 30D
26.5%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-26.3%
Peak to trough
Max drawdown 5Y
-42.7%
Peak to trough
ATR 14
0.33
1.87% of price
Beta (reported)
—
5Y monthly, from filing
Headlines
James Hardie Industries to Sell Fermacell to Holcim for $981 Million
MT Newswires · 2d ago
James Hardie Announces Strategic Divestiture of European Operations, Including Sale of Fermacell to Holcim for €840 Million
Business Wire · 2d ago
HLMN vs. HCMLY: Which Stock Is the Better Value Option?
Zacks · 17d ago
Cementos Pacasmayo S.A.A. Q2 Earnings Call Highlights
MarketBeat · 32d ago
Holcim Warns Labor Shortage Could Slow Europe Construction Recovery
GuruFocus.com · 59d ago
Lone Star Funds Completes Sale of Xella to Holcim
Business Wire · 65d ago
[Latest] Global Limestone Market Size/Share Worth USD 176.50 Billion by 2035 at a 7.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
GlobeNewswire · 67d ago
Discover Three European Stocks That May Be Trading Below Estimated Value
Simply Wall St. · 69d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.